0
0

Securing America’s Pharmaceutical Supply Chain Act

12/30/2022, 5:32 PM

Summary of Bill HR 3683

Bill 117 HR 3683, also known as the Securing America's Pharmaceutical Supply Chain Act, aims to enhance the security of the pharmaceutical supply chain in the United States. The bill was introduced in the House of Representatives and is currently under consideration.

The main purpose of this legislation is to prevent counterfeit or substandard drugs from entering the US market by implementing stricter regulations and oversight measures. The bill requires pharmaceutical manufacturers, distributors, and other entities involved in the supply chain to establish and maintain systems for tracking and tracing prescription drugs.

Additionally, the Securing America's Pharmaceutical Supply Chain Act mandates the use of serialization technology to ensure the authenticity of prescription drugs throughout the supply chain. This technology allows for the unique identification and tracking of individual drug packages, making it easier to detect and prevent the distribution of counterfeit drugs. Furthermore, the bill requires the establishment of a national database to track and verify the authenticity of prescription drugs. This database will be accessible to authorized stakeholders, including regulators, law enforcement agencies, and healthcare providers, to help ensure the safety and integrity of the pharmaceutical supply chain. Overall, the Securing America's Pharmaceutical Supply Chain Act aims to protect consumers from the risks associated with counterfeit drugs and strengthen the security of the US pharmaceutical supply chain. The bill is currently being reviewed by Congress and may undergo further revisions before being enacted into law.

Congressional Summary of HR 3683

Securing America's Pharmaceutical Supply Chain Act

This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.

This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.

The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill HR 3683

Bill HR 3683 is currently in the status of Bill Introduced since June 1, 2021. Bill HR 3683 was introduced during Congress 117 and was introduced to the House on June 1, 2021.  Bill HR 3683's most recent activity was Referred to the Subcommittee on Trade. as of June 1, 2021

Bipartisan Support of Bill HR 3683

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
2
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 3683

Primary Policy Focus

Government Operations and Politics

Alternate Title(s) of Bill HR 3683

Securing America’s Pharmaceutical Supply Chain Act
To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.
Securing America’s Pharmaceutical Supply Chain Act

Comments

Sponsors and Cosponsors of HR 3683

Pete Stauber
Pete Stauber
MinnesotaRepublican
John Garamendi
John Garamendi
CaliforniaDemocrat

Latest Bills

To authorize the Secretary of Education, in collaboration with the Secretary of Health and Human Services, to establish an interagency advisory Commission on Advancing Restorative Justice in Elementary and Secondary Education, and for other purposes.
Bill HR 8360April 17, 2026
To amend the Higher Education Act of 1965 to remove all adverse credit history related to a loan from the credit history of a borrower who has rehabilitated the loan.
Bill HR 8361April 17, 2026
To reauthorize the YouthBuild program, and for other purposes.
Bill HR 8333April 17, 2026
To raise the Foreign Service mandatory retirement age by aligning it with the Social Security Full Retirement Age, and for other purposes.
Bill HR 8346April 17, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 17, 2026
To amend title II of the Social Security Act to repeal the retirement earnings test, and for other purposes.
Bill HR 8344April 17, 2026
To amend section 133 of title 23, United States Code, to remove a certain State funding set-aside for transportation alternative programs, and for other purposes.
Bill HR 8349April 17, 2026
To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to reduce chronic diseases by using accountable produce is medicine.
Bill HR 8355April 17, 2026
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Bill HR 8339April 17, 2026
Supporting the designation of the week of April 11 through April 17, 2026, as "Black Maternal Health Week", founded by Black Mamas Matter Alliance, Inc. (BMMA), to bring national attention to the maternal and reproductive health crisis in the United States and the importance of reducing maternal mortality and morbidity among Black women and birthing people.
Bill HRES 1183April 17, 2026